↓ Skip to main content

Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening

Overview of attention for article published in Annals of Oncology, September 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

policy
1 policy source
twitter
10 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
162 Dimensions

Readers on

mendeley
391 Mendeley
Title
Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening
Published in
Annals of Oncology, September 2016
DOI 10.1093/annonc/mdw327
Pubmed ID
Authors

S. Paluch-Shimon, F. Cardoso, C. Sessa, J. Balmana, M.J. Cardoso, F. Gilbert, E. Senkus

Twitter Demographics

The data shown below were collected from the profiles of 10 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 391 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 391 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 77 20%
Researcher 47 12%
Student > Master 38 10%
Other 36 9%
Student > Ph. D. Student 32 8%
Other 74 19%
Unknown 87 22%
Readers by discipline Count As %
Medicine and Dentistry 183 47%
Biochemistry, Genetics and Molecular Biology 50 13%
Nursing and Health Professions 15 4%
Agricultural and Biological Sciences 11 3%
Pharmacology, Toxicology and Pharmaceutical Science 6 2%
Other 31 8%
Unknown 95 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 August 2019.
All research outputs
#2,367,467
of 17,455,239 outputs
Outputs from Annals of Oncology
#1,395
of 6,572 outputs
Outputs of similar age
#50,323
of 275,270 outputs
Outputs of similar age from Annals of Oncology
#43
of 274 outputs
Altmetric has tracked 17,455,239 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,572 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.5. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 275,270 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 274 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.